Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

528
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
528
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

5.2K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
5.2K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Hematopoiesis01:21

Hematopoiesis

5.8K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systemic STING agonist therapy drives expression of interferon stimulated genes and downstream production of cytokines in dogs with solid tumors.

Journal for immunotherapy of cancer·2025
Same author

Immune profiling of canine B cell lymphoma reveals cross-species conservation of prognostic markers.

Scientific reports·2025
Same author

Maximizing the dual benefit of pet dogs in cancer trials.

Nature reviews. Cancer·2025
Same author

Identification of immune suppressor candidates utilizing comparative transcriptional profiling in histiocytic sarcoma.

Cancer immunology, immunotherapy : CII·2025
Same author

Malignant transformation and subsequent leptomeningeal carcinomatosis of a gastric polyp in a dog.

Journal of veterinary internal medicine·2024
Same author

Applications and Opportunities for Immune Cell CAR Engineering in Comparative Oncology.

Clinical cancer research : an official journal of the American Association for Cancer Research·2024

Related Experiment Video

Updated: Sep 29, 2025

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.4K

Bite-size introduction to canine hematologic malignancies.

Matthew J Atherton1,2, Nicola J Mason1,3

  • 1Department of Clinical Sciences and Advanced Medicine.

Blood Advances
|March 22, 2022
PubMed
Summary
This summary is machine-generated.

This review provides an introduction to canine hematologic malignancies, covering common types like lymphoma and leukemia. It discusses their varied clinical signs, treatments, and similarities to human cancers, highlighting dogs as models for comparative oncology research.

More Related Videos

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

9.9K
A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model
08:00

A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model

Published on: October 14, 2016

20.5K

Related Experiment Videos

Last Updated: Sep 29, 2025

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.4K
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

9.9K
A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model
08:00

A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model

Published on: October 14, 2016

20.5K

Area of Science:

  • Veterinary Oncology
  • Comparative Pathology
  • Canine Cancer Research

Background:

  • Hematologic malignancies are common in dogs, presenting diverse clinical signs and variable outcomes.
  • Common canine hematologic tumors include lymphoma, leukemias, mast cell, plasma cell, and histiocytic neoplasias.
  • The pathology of canine hematologic cancers often mirrors human counterparts.

Purpose of the Study:

  • To provide an introductory overview of canine hematologic malignancies.
  • To discuss pathogenic drivers and clinical presentations of these cancers.
  • To outline standard-of-care therapies for canine hematologic tumors.

Main Methods:

  • Review of existing literature on canine hematologic malignancies.
  • Discussion of pathogenic mechanisms and clinical manifestations.
  • Summary of current therapeutic strategies, including surgery, chemotherapy, and radiation.

Main Results:

  • Identified common types of canine hematologic malignancies and their characteristics.
  • Highlighted the variability in clinical presentation and prognosis.
  • Emphasized the similarities between canine and human hematologic cancers.

Conclusions:

  • Canine hematologic malignancies represent a significant area of veterinary oncology.
  • Dogs serve as valuable immunocompetent models for comparative oncology research.
  • Understanding these cancers aids in developing novel therapeutic approaches for both canine and human patients.